None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subject able to read, understand and sign on informed consent form indicating willingness to participate in the study. 2. Subjects of both genders in age group 18 55 years (both the ages inclusive). 3. Subjects with a colorimetric ITA value in the range of 20-41 Degrees, providing persistent pigmentation darkening to the UVA dose. (Phototype of the subject will be recorded) 4. Subjects having a clear back with uniform colour and no sunburn (erythema), tan, blemishes, cuts, wounds, injuries, allergies, or any skin condition on the test areas (Upper back region between scapula and waist) that can hamper the assessment. 5. Subjects willing to discontinue the use of soaps and cosmetic products (e.g., creams, moisturizers) in the treatment areas throughout the course of the study. 6. Subject willing to avoid any exposure of the test area to artificial or natural Ultraviolet (UV) light throughout the course of the study. 7. Subjects willing to adhere to the study procedure, restrictions and vising the study site for follow up visits at the specified date and time. 8. Subjects with no known abnormal response to sunlight. 9. Subjects willing and capable to follow the study rules and a fixed schedule.
Exclusion criteria
Exclusion criteria: 1. Subjects with sun tan, blemishes, photo-toxicity reactions, cuts, abrasions, wounds, injuries, allergic reactions (in the tested area). 2. Subjects allergic to cosmetic products such as moisturizers, creams and body lotion or anything else. 3. Skin allergy antecedents or atopic subjects. 4. Subjects having history of or having active photo dermatitis. 5. Subjects on any known medication for photosensitization. (eg. oral diabetic medications, Sulphur drugs, cancer chemotherapy) 6. Subjects with cutaneous disease which may influence the study result. 7. Subjects on oral corticosteroid in last 2 months. 8. Subjects participating in any other cosmetic or therapeutic study. 9. Subjects who are pregnant or lactating 10. Subjects with any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness. 11. Subjects who have participated in a similar investigation in the past 8 weeks. 12. Subjects who are currently an employee of MSCR or the sponsor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in delayed Erythema ResponseTimepoint: Day1, Day2 | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
CCFT Laboratories